Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization.
about
14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transitionMolecular imaging of integrin αvβ6 expression in living subjects.Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferationHER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerStructure and functions of profilinsBCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization.The cooperation between hMena overexpression and HER2 signalling in breast cancerProteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma.Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in miceBiologic and therapeutic role of HER2 in cancer.4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugsUbiquitin E3 ligase MARCH7 promotes ovarian tumor growthLocal variations of HER2 dimerization in breast cancer cells discovered by correlative fluorescence and liquid electron microscopyWhole genome expression analysis for biologic rational pathway modeling: application in cancer prognosis and therapy prediction.MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells.Molecular targeted therapies for breast cancer treatment.Signal transduction in cells of the immune system in microgravity.DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).Defining the role of integrin alphavbeta6 in cancer.Association with membrane protrusions makes ErbB2 an internalization-resistant receptor.Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells.MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad.When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase.The size-speed-force relationship governs migratory cell response to tumorigenic factors.Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells.Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domain.FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion.Modulation of glioma BK channels via erbB2.A neural Wiskott-Aldrich Syndrome protein-mediated pathway for localized activation of actin polymerization that is regulated by cortactin.MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1.The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein.The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis.Inositol 1,4,5-trisphosphate 3-kinase-A is a new cell motility-promoting protein that increases the metastatic potential of tumor cells by two functional activities.Analysis of pathway mutation profiles highlights collaboration between cancer-associated superpathways.Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.Ubiquitin E3 Ligase MARCH7 promotes proliferation and invasion of cervical cancer cells through VAV2-RAC1-CDC42 pathway.M-CSF Regulates the Cytoskeleton via Recruitment of a Multimeric Signaling Complex to c-Fms Tyr-559/697/721
P2860
Q24313042-10BDFDCD-E73C-4EC6-AFC6-D2854AAFB4CDQ27007536-14FD6B8E-DBB0-4174-A45F-AFC3434DD0BDQ27648499-2E37E789-5BAB-4150-9865-8F4C917ED9C1Q28085413-997DAA49-6A94-48B6-901F-21C352AC904AQ33659236-659A3471-E95B-430B-96A1-3B273754D2F3Q33766199-44D1A4F4-A034-48F5-88C6-306BB637BAB0Q33786779-B49BAEB1-97D7-4277-8D1F-6AA05B7CD2B5Q33801496-C4CEC232-5E0F-4C3D-9DF6-D41B75095AB7Q34028716-55B99847-2FF1-4A88-BAFE-F512975ACAD0Q34267775-0CD50A25-45A5-49A5-A695-A5E3DB7BE508Q35812711-A37D33A0-D505-4A3D-878D-3AFBB9371995Q35828527-D17CA708-A7D1-4A44-8F4B-3BB239B9C7ADQ36284765-2DAA7EDE-72EC-4AFA-87A6-79F54437F397Q36615223-46924F47-CDF2-4FDE-9B12-21BE61F0EEB4Q36858047-319BF834-F50F-4A70-98AC-C5298B1530E5Q36955065-2D2BBE5B-307B-49D7-A029-23233B0945C1Q36975154-3B00FE9A-7E99-4F0A-9646-B0772B14E7C0Q36977266-07B0CE9B-10DF-4FA6-B8E2-409498312A4AQ37407344-4A5970CE-2E67-4172-8F8F-B2941AAB9DDFQ37550644-0061ED09-EEA6-498B-B759-6993CA8DEDC1Q38345553-97DA79F0-541B-411D-A06A-7B219D30772BQ38346601-2F735A81-D756-420D-9537-555D396F2212Q38373190-C364A607-BDC8-4B54-B15B-3EE20EC557FDQ38673589-70CC8FF3-0185-4D13-8A93-B00880692C42Q38706625-B1A6B5F5-1839-4004-81BD-E30BEC004D86Q39500296-5F72F6AF-D905-4C89-B33D-0B199629E854Q39690631-6DB13DE7-72C0-4947-9D2F-B69C8335BB59Q40353474-16008A55-B9CD-458B-BFB2-1F6436782BFBQ40411360-997C17B9-EA05-42DE-A76C-080A68389967Q40484725-FDA06A88-9276-49CF-BE04-A851164F680DQ40550805-3E3F9D3A-7ADF-429D-AAF2-45B3364D672DQ40567628-12B988F2-BCB1-434F-A503-C52B18CE7E6CQ41953800-CE0054E6-9746-4B81-B28B-65A013EF62AAQ42464646-0E48E972-65DE-4E7B-B457-EBB68B072066Q53286403-436BBE04-31E4-4D60-98A9-239CC8AFF8C6Q54610409-69686D11-079D-4A6F-AFB2-F95058C01A8FQ55618419-ED551F8F-C97F-4C86-B030-1183B5CB8C13Q58085231-BF6D71EE-0ADF-4804-A30F-A9DBE77694BA
P2860
Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cancer cell motility--on the r ...... aling to actin reorganization.
@ast
Cancer cell motility--on the r ...... aling to actin reorganization.
@en
Cancer cell motility--on the r ...... aling to actin reorganization.
@nl
type
label
Cancer cell motility--on the r ...... aling to actin reorganization.
@ast
Cancer cell motility--on the r ...... aling to actin reorganization.
@en
Cancer cell motility--on the r ...... aling to actin reorganization.
@nl
prefLabel
Cancer cell motility--on the r ...... aling to actin reorganization.
@ast
Cancer cell motility--on the r ...... aling to actin reorganization.
@en
Cancer cell motility--on the r ...... aling to actin reorganization.
@nl
P356
P1476
Cancer cell motility--on the r ...... aling to actin reorganization.
@en
P2093
Burkhard H Brandt
Julia C Feldner
P304
P356
10.1006/EXCR.2001.5385
P407
P577
2002-01-01T00:00:00Z